Maurizio Fava, MD

Original Research

Nortriptyline for Treatment-Resistant Depression

January 15, 2003

Andrew A. Nierenberg , George I. Papakostas , Timothy Petersen , et al

Original Research

An Open Study of Olanzapine and Fluoxetine for Psychotic Major Depressive Disorder: Interim Analyses.

December 1, 2002

John D. Matthews , Kathryn A. Bottonari , Laura M. Polania , et al

Article

Sexual Functioning and SSRIs

May 1, 2002

Maurizio Fava , Meridith Rankin

Article

Sexual Functioning and SSRIs

May 1, 2002

Maurizio Fava , Meridith Rankin

Original Research

Somatic Symptoms, Depression, and Antidepressant Treatment

April 1, 2002

Maurizio Fava

Original Research

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

June 1, 2001

Maurizio Fava , David L. Dunner , John H. Greist , et al

Article

Augmentation and Combination Strategies in Treatment-Resistant Depression

January 4, 2001

Maurizio Fava

Original Research

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

November 30, 2000

Steffany J. Fredman , Maurizio Fava , Allison S. Kienke , et al

Original Research

The Efficacy and Safety of a New Enteric-Coated Formulation of Fluoxetine Given Once Weekly During the Continuation Treatment of Major Depressive Disorder

October 31, 2000

Mark E. Schmidt , Maurizio Fava , James M. Robinson , et al

Original Research

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder: Changes in Weight With Long-Term Treatment

October 31, 2000

Maurizio Fava , Rajinder Judge , Sharon L. Hoog , et al

Article

Weight Gain and Antidepressants

September 30, 2000

Maurizio Fava

Article

Weight Gain and Antidepressants

September 30, 2000

Maurizio Fava

Nortriptyline for Treatment-Resistant Depression

An Open Study of Olanzapine and Fluoxetine for Psychotic Major Depressive Disorder: Interim Analyses.

Sexual Functioning and SSRIs

Sexual Functioning and SSRIs

Somatic Symptoms, Depression, and Antidepressant Treatment

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

Augmentation and Combination Strategies in Treatment-Resistant Depression

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

The Efficacy and Safety of a New Enteric-Coated Formulation of Fluoxetine Given Once Weekly During the Continuation Treatment of Major Depressive Disorder

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder: Changes in Weight With Long-Term Treatment

Weight Gain and Antidepressants

Weight Gain and Antidepressants

ELSEWHERE:

FOLLOW US:

Maurizio Fava, MD

Nortriptyline for Treatment-Resistant Depression

An Open Study of Olanzapine and Fluoxetine for Psychotic Major Depressive Disorder: Interim Analyses.

Sexual Functioning and SSRIs

Sexual Functioning and SSRIs

Somatic Symptoms, Depression, and Antidepressant Treatment

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

Augmentation and Combination Strategies in Treatment-Resistant Depression

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

The Efficacy and Safety of a New Enteric-Coated Formulation of Fluoxetine Given Once Weekly During the Continuation Treatment of Major Depressive Disorder

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder: Changes in Weight With Long-Term Treatment

Weight Gain and Antidepressants

Weight Gain and Antidepressants

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles